- June 23, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Infectious Disease » CNS Infections » Whipple Disease
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Infectious Disease » CNS Infections » Whipple Disease
Background
Tropheryma whippelii is a gram-positive bacterium that causes Whipple illness. This is really a systemic condition that affects the cardiovascular, CNS, vascular systems, and joints in addition to the gastrointestinal tract’s malabsorption. This syndrome was first explained by Dr. George Hoyt Whipple in 1907.
He received the Physiology Nobel Prize as the first American. Dr. Whipple discussed the example of a thirty-six-year-old man who had skin pigmentation, arthralgias, and mesenteric lymphadenopathy in addition to malabsorption.
His report was posted in the Johns Hopkins Hospital Bulletin, and he gave the condition the term “Intestinal Lipodystrophy.” Although he postulated infectious organisms as the cause, the bacteria weren’t properly discovered until 1992. Whipple disease is uncommon, and the literature solely contains case accounts.
Epidemiology
Whipple syndrome is a rare ailment in the world, with the majority of reports coming from Europe and North America. The HLA B27 haplotype is connected to the illness. Around one to three persons out of every million are affected by Whipple illness globally.
The average age at which symptoms first appear is 55. With such a ratio of 4:1, men experience it significantly more frequently than women do. The increasing occurrence in farmers is likely due to the organism’s apparent soil habitation.
Anatomy
Pathophysiology
Although the precise pathophysiology is yet unknown, there is enough data to suggest that host immunity plays a significant role. The majority of people who get T. whippelii are asymptomatic carriers or only have a mild illness, which is followed by the emergence of cellular and humoral defenses.
The immune response to the organism is less in sick people. It mostly comprises type 1 T-cell reaction that is compromised as well as impaired macrophage activation and activity. Shigella flexneri and Streptococcal groups B and G are antigenically similar to Whipple bacillus.
The 2- to 3-fold rise in HLA-B27 antigen frequency across individuals affected suggests that host factors play a significant role in the pathogenesis. The macrophages that can be seen in periodic acid-Schiff consume the creature. Sadly, Whipple disease cannot be diagnosed by looking for periodic acid-Schiff-stained macrophages.
Coccobacillus particles that refract the species may be seen under an electron microscope. The natural villus activity has been disturbed, which results in the observed malabsorption. The microorganism can be discovered in numerous tissues whenever systemic illness develops.
Etiology
1992 saw the description of Tropheryma whipplei. It was given the name Tropheryma whippelii up till 2001 when its name was changed to reflect Dr. George Hoyt Whipple’s correct spelling. It is an acid-fast negative, periodic acid-Schiff positive (PAS), and gram-positive bacillus.
The bacillus core is encased in a plasma membrane, which is encircled by a three-layered cell wall, according to electron microscopy findings. Polysaccharides that PAS positively stain are present inside the inner lining.
The host’s inability to produce a humoral antibody production towards the infection may be explained by the outermost layer, which mimics a plasma membrane and could be of host source.
Genetics
Prognostic Factors
With quick identification and management of Whipple’s illness, the prognosis is typically favorable. Between 2 to 3 weeks of starting the treatment, the patients report feeling significantly better. Patients who are not treated have a dismal prognosis.
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Future Trends
References
https://www.ncbi.nlm.nih.gov/books/NBK441937/
ADVERTISEMENT
» Home » CAD » Infectious Disease » CNS Infections » Whipple Disease
Tropheryma whippelii is a gram-positive bacterium that causes Whipple illness. This is really a systemic condition that affects the cardiovascular, CNS, vascular systems, and joints in addition to the gastrointestinal tract’s malabsorption. This syndrome was first explained by Dr. George Hoyt Whipple in 1907.
He received the Physiology Nobel Prize as the first American. Dr. Whipple discussed the example of a thirty-six-year-old man who had skin pigmentation, arthralgias, and mesenteric lymphadenopathy in addition to malabsorption.
His report was posted in the Johns Hopkins Hospital Bulletin, and he gave the condition the term “Intestinal Lipodystrophy.” Although he postulated infectious organisms as the cause, the bacteria weren’t properly discovered until 1992. Whipple disease is uncommon, and the literature solely contains case accounts.
Whipple syndrome is a rare ailment in the world, with the majority of reports coming from Europe and North America. The HLA B27 haplotype is connected to the illness. Around one to three persons out of every million are affected by Whipple illness globally.
The average age at which symptoms first appear is 55. With such a ratio of 4:1, men experience it significantly more frequently than women do. The increasing occurrence in farmers is likely due to the organism’s apparent soil habitation.
Although the precise pathophysiology is yet unknown, there is enough data to suggest that host immunity plays a significant role. The majority of people who get T. whippelii are asymptomatic carriers or only have a mild illness, which is followed by the emergence of cellular and humoral defenses.
The immune response to the organism is less in sick people. It mostly comprises type 1 T-cell reaction that is compromised as well as impaired macrophage activation and activity. Shigella flexneri and Streptococcal groups B and G are antigenically similar to Whipple bacillus.
The 2- to 3-fold rise in HLA-B27 antigen frequency across individuals affected suggests that host factors play a significant role in the pathogenesis. The macrophages that can be seen in periodic acid-Schiff consume the creature. Sadly, Whipple disease cannot be diagnosed by looking for periodic acid-Schiff-stained macrophages.
Coccobacillus particles that refract the species may be seen under an electron microscope. The natural villus activity has been disturbed, which results in the observed malabsorption. The microorganism can be discovered in numerous tissues whenever systemic illness develops.
1992 saw the description of Tropheryma whipplei. It was given the name Tropheryma whippelii up till 2001 when its name was changed to reflect Dr. George Hoyt Whipple’s correct spelling. It is an acid-fast negative, periodic acid-Schiff positive (PAS), and gram-positive bacillus.
The bacillus core is encased in a plasma membrane, which is encircled by a three-layered cell wall, according to electron microscopy findings. Polysaccharides that PAS positively stain are present inside the inner lining.
The host’s inability to produce a humoral antibody production towards the infection may be explained by the outermost layer, which mimics a plasma membrane and could be of host source.
With quick identification and management of Whipple’s illness, the prognosis is typically favorable. Between 2 to 3 weeks of starting the treatment, the patients report feeling significantly better. Patients who are not treated have a dismal prognosis.
https://www.ncbi.nlm.nih.gov/books/NBK441937/
Tropheryma whippelii is a gram-positive bacterium that causes Whipple illness. This is really a systemic condition that affects the cardiovascular, CNS, vascular systems, and joints in addition to the gastrointestinal tract’s malabsorption. This syndrome was first explained by Dr. George Hoyt Whipple in 1907.
He received the Physiology Nobel Prize as the first American. Dr. Whipple discussed the example of a thirty-six-year-old man who had skin pigmentation, arthralgias, and mesenteric lymphadenopathy in addition to malabsorption.
His report was posted in the Johns Hopkins Hospital Bulletin, and he gave the condition the term “Intestinal Lipodystrophy.” Although he postulated infectious organisms as the cause, the bacteria weren’t properly discovered until 1992. Whipple disease is uncommon, and the literature solely contains case accounts.
Whipple syndrome is a rare ailment in the world, with the majority of reports coming from Europe and North America. The HLA B27 haplotype is connected to the illness. Around one to three persons out of every million are affected by Whipple illness globally.
The average age at which symptoms first appear is 55. With such a ratio of 4:1, men experience it significantly more frequently than women do. The increasing occurrence in farmers is likely due to the organism’s apparent soil habitation.
Although the precise pathophysiology is yet unknown, there is enough data to suggest that host immunity plays a significant role. The majority of people who get T. whippelii are asymptomatic carriers or only have a mild illness, which is followed by the emergence of cellular and humoral defenses.
The immune response to the organism is less in sick people. It mostly comprises type 1 T-cell reaction that is compromised as well as impaired macrophage activation and activity. Shigella flexneri and Streptococcal groups B and G are antigenically similar to Whipple bacillus.
The 2- to 3-fold rise in HLA-B27 antigen frequency across individuals affected suggests that host factors play a significant role in the pathogenesis. The macrophages that can be seen in periodic acid-Schiff consume the creature. Sadly, Whipple disease cannot be diagnosed by looking for periodic acid-Schiff-stained macrophages.
Coccobacillus particles that refract the species may be seen under an electron microscope. The natural villus activity has been disturbed, which results in the observed malabsorption. The microorganism can be discovered in numerous tissues whenever systemic illness develops.
1992 saw the description of Tropheryma whipplei. It was given the name Tropheryma whippelii up till 2001 when its name was changed to reflect Dr. George Hoyt Whipple’s correct spelling. It is an acid-fast negative, periodic acid-Schiff positive (PAS), and gram-positive bacillus.
The bacillus core is encased in a plasma membrane, which is encircled by a three-layered cell wall, according to electron microscopy findings. Polysaccharides that PAS positively stain are present inside the inner lining.
The host’s inability to produce a humoral antibody production towards the infection may be explained by the outermost layer, which mimics a plasma membrane and could be of host source.
With quick identification and management of Whipple’s illness, the prognosis is typically favorable. Between 2 to 3 weeks of starting the treatment, the patients report feeling significantly better. Patients who are not treated have a dismal prognosis.
https://www.ncbi.nlm.nih.gov/books/NBK441937/
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.